Ascend Wellness Holdings (AAWH) Profit After Tax (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Profit After Tax came in at -$29.5 million in Q1 2026, down 53.15% year-on-year from -$62.9 million in Q1 2025, and up 39.44% quarter-over-quarter from -$48.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Profit After Tax (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Profit After Tax history runs 7 years deep, the most recent figure standing at -$29.5 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 53.15% year-over-year to -$29.5 million in Q1 2026; TTM through Mar 2026 was -$128.4 million, a 49.18% decrease from a year earlier, with the FY2025 full-year figure at -$118.2 million, down 39.06% from the prior year.
- Profit After Tax rose to -$29.5 million in Q1 2026 per AAWH's latest filing, from -$48.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $841000.0 in Q2 2023 and bottomed at -$48.7 million in Q4 2025.
- The 5-year median for Profit After Tax is -$19.3 million (2023), against an average of -$21.3 million.
- Across the five-year window, Profit After Tax jumped 103.97% in 2023 and plunged 2690.25% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$15.0 million in 2022, then slipped by 28.52% to -$19.3 million in 2023, then advanced by 13.19% to -$16.8 million in 2024, then plunged by 190.05% to -$48.7 million in 2025, then jumped by 39.44% to -$29.5 million in 2026.
- Per Business Quant, the three latest AAWH Profit After Tax figures stand at -$29.5 million (Q1 2026), -$48.7 million (Q4 2025), and -$25.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.19 Bn | 87.33 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.22 Bn | 21.07 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.48 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | -29.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.49 Mn |
| Dec 31, 2025 | -48.70 Mn |
| Sep 30, 2025 | -25.83 Mn |
| Jun 30, 2025 | -24.41 Mn |
| Mar 31, 2025 | -19.26 Mn |
| Dec 31, 2024 | -16.79 Mn |
| Sep 30, 2024 | -28.26 Mn |
| Jun 30, 2024 | -21.78 Mn |
| Mar 31, 2024 | -18.16 Mn |
| Dec 31, 2023 | -19.34 Mn |
| Sep 30, 2023 | -11.24 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | -18.47 Mn |
| Dec 31, 2022 | -15.05 Mn |
| Sep 30, 2022 | -16.86 Mn |
| Jun 30, 2022 | -21.17 Mn |
| Mar 31, 2022 | -27.82 Mn |
| Dec 31, 2021 | -16.51 Mn |
| Sep 30, 2021 | -13.03 Mn |
| Jun 30, 2021 | -44.90 Mn |